ezetimibe has been researched along with allylamine in 20 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (allylamine) | Trials (allylamine) | Recent Studies (post-2010) (allylamine) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 734 | 112 | 217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (75.00) | 29.6817 |
| 2010's | 5 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, WV | 1 |
| Farmer, JA; Manhas, A | 1 |
| Ballantyne, CM; Chiou, P; Guyton, JR; Jones, PH; Stein, JL; Xydakis, AM | 1 |
| McKenney, JM | 1 |
| Gylling, H; Miettinen, TA | 1 |
| Armani, A; Toth, PP | 1 |
| Abby, S; Bays, H; Jones, M; Lai, YL; Rhyne, J | 1 |
| Anderson, S; Fish, B; Knopp, RH; Nguyen, H; Nguyen, T; Retzlaff, BM; Tsunehara, C | 1 |
| Elisaf, MS; Florentin, M; Liberopoulos, EN; Mikhailidis, DP | 1 |
| Robinson, JG | 1 |
| Bangit, JR; Batsell, RR; John, S; Molinella, R; Reddy, KJ; Singh, M; Varghese, S; Zaheer, MS | 1 |
| Abbink, EJ; Bruckert, E; Durrington, PN; Eriksson, M; Huijgen, R; Imholz, BP; Kastelein, JJ; Schaefer, JR; Stalenhoef, AF; Trip, MD; Visseren, FL | 1 |
| Bangit, JR; Batsell, RR; Miraskar, RA; Reddy, KJ; Singh, M; Zaheer, MS | 1 |
| Lee, T | 1 |
| Davidson, M | 1 |
| Bays, H; Li, Y; Louder, A; Mallick, R; Schwab, P | 1 |
8 review(s) available for ezetimibe and allylamine
| Article | Year |
|---|---|
Promising therapies for cholesterol reduction.
Topics: Allylamine; Anticholesteremic Agents; Arteriosclerosis; Azetidines; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, LDL; Colesevelam Hydrochloride; Ezetimibe; Glycoproteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Receptors, Cytoplasmic and Nuclear; Sterol O-Acyltransferase; Sulfonic Acids; Transcription Factors; United States | 2002 |
Hypolipidemic therapy and cholesterol absorption.
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol; Colesevelam Hydrochloride; Ezetimibe; Humans; Hypercholesterolemia; Intestinal Absorption | 2004 |
Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
Topics: Allylamine; Anticholesteremic Agents; Atorvastatin; Azetidines; Cholesterol, LDL; Clinical Trials as Topic; Colesevelam Hydrochloride; Coronary Artery Disease; Drug Therapy, Combination; Ezetimibe; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Muscular Diseases; Niacin; Pyrimidines; Pyrroles; Rhabdomyolysis; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Treatment Outcome | 2005 |
Drug-induced effects on cholesterol catabolism and bile acids.
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Bile Acids and Salts; Cholesterol; Colesevelam Hydrochloride; Epichlorohydrin; Ezetimibe; Humans; Imidazoles; Resins, Synthetic | 2006 |
Colesevelam hydrochloride in the management of dyslipidemia.
Topics: Allylamine; Anion Exchange Resins; Anticholesteremic Agents; Azetidines; Colesevelam Hydrochloride; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Patient Compliance | 2006 |
Colesevelam hydrochloride in clinical practice: a new approach in the treatment of hypercholesterolaemia.
Topics: Allylamine; Anticholesteremic Agents; Apolipoproteins B; Azetidines; Bile Acids and Salts; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Risk Factors | 2008 |
LDL reduction: how low should we go and is it safe?
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Ezetimibe; Fenofibrate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Muscular Diseases; Niacin; Risk Factors; Stroke | 2008 |
The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Gastrointestinal Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Young Adult | 2013 |
4 trial(s) available for ezetimibe and allylamine
| Article | Year |
|---|---|
Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
Topics: Adult; Aged; Aged, 80 and over; Allylamine; Apolipoprotein A-I; Apolipoproteins B; Azetidines; Cholesterol; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Hypolipidemic Agents; Male; Middle Aged; Patient Compliance; Treatment Outcome | 2006 |
Lipoprotein effects of combined ezetimibe and colesevelam hydrochloride versus ezetimibe alone in hypercholesterolemic subjects: a pilot study.
Topics: Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, HDL; Cholesterol, LDL; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Pilot Projects; Triglycerides | 2006 |
Colesevelam added to combination therapy with a statin and ezetimibe in patients with familial hypercholesterolemia: a 12-week, multicenter, randomized, double-blind, controlled trial.
Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Apolipoproteins; Azetidines; Body Mass Index; Cholesterol; Colesevelam Hydrochloride; Double-Blind Method; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Smoking; Triglycerides; Young Adult | 2010 |
The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
Topics: Adolescent; Adult; Aged; Allylamine; Anticholesteremic Agents; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Coronary Artery Disease; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ezetimibe; Female; Gastrointestinal Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male; Middle Aged; Young Adult | 2013 |
9 other study(ies) available for ezetimibe and allylamine
| Article | Year |
|---|---|
Beyond statins. New drugs can work with, or in place of, cholesterol-lowering statins.
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Colesevelam Hydrochloride; Ezetimibe; Humans | 2003 |
Effectiveness and tolerability of ezetimibe add-on therapy to a bile acid resin-based regimen for hypercholesterolemia.
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cholestyramine Resin; Colesevelam Hydrochloride; Colestipol; Drug Therapy, Combination; Ezetimibe; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2004 |
Lower cholesterol without statins. Options are available.
Topics: Allylamine; Azetidines; Cholesterol, LDL; Cholinergic Antagonists; Colesevelam Hydrochloride; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Niacin; Phytosterols | 2006 |
I am a 74-year-old woman who walks every day and am not overweight. I had a stent put in two-and-a-half years ago. I have high blood pressure and cholesterol problems. I have tried all the statins and every one causes muscle pains. The pain gets so bad th
Topics: Aged; Allylamine; Anticholesteremic Agents; Azetidines; Colesevelam Hydrochloride; Diet; Exercise; Ezetimibe; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pain; Sleep Wake Disorders | 2007 |
What role for [black triangle down] colesevelam in cardiovascular prevention?
Topics: Allylamine; Anticholesteremic Agents; Azetidines; Cardiovascular Diseases; Colesevelam Hydrochloride; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Treatment Outcome | 2009 |
Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use.
Topics: Allylamine; Analysis of Variance; Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Azetidines; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Monitoring; Drug Therapy, Combination; Ezetimibe; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lipids; Male; Middle Aged; Pulse Therapy, Drug; Pyrimidines; Pyrroles; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides | 2009 |
Lipoprotein-associated phospholipase A2 mass is significantly reduced in dyslipidemic patients treated with lifestyle modification and combination lipid-modifying drug therapy.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Allylamine; Anticholesteremic Agents; Azetidines; Biomarkers; Cholesterol, LDL; Colesevelam Hydrochloride; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Fatty Acids, Omega-3; Female; Humans; Inflammation; Life Style; Male; Middle Aged; Niacin; Regression Analysis; Retrospective Studies; Risk Factors; Simvastatin; Statistics as Topic; Vitamin B Complex | 2010 |
Ask the doctor. I have tried all of the statin drugs to lower my cholesterol, but each one has caused severe muscle pain. Are there any non-statin medications I could try using to lower my cholesterol?
Topics: Allylamine; Azetidines; Colesevelam Hydrochloride; Diet, Mediterranean; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypolipidemic Agents; Muscular Diseases; Niacin; Pain; Sitosterols | 2010 |
Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Allylamine; Anticholesteremic Agents; Azetidines; Cohort Studies; Colesevelam Hydrochloride; Coronary Artery Disease; Diagnosis-Related Groups; Ezetimibe; Female; Health Services for the Aged; Humans; Hypercholesterolemia; Male; Middle Aged; Retrospective Studies; Treatment Outcome; United States | 2014 |